Upregulation	upregulation	O	O
of	of	O	O
brain	brain	O	O
expression	expression	O	O
of	of	O	O
P-glycoprotein	p-glycoprotein	O	O
in	in	O	O
MRP2-deficient	mrp2-deficient	O	O
TR(-	tr(-	O	O
)	)	O	O
rats	rats	O	O
resembles	resembles	O	O
seizure-induced	seizure-induced	O	O
up-regulation	up-regulation	O	O
of	of	O	O
this	this	O	O
drug	drug	O	O
efflux	efflux	O	O
transporter	transporter	O	O
in	in	O	O
normal	normal	O	O
rats	rats	O	O
.	.	O	O

PURPOSE	purpose	O	O
:	:	O	O
The	the	O	O
multidrug	multidrug	O	O
resistance	resistance	O	O
protein	protein	O	O
2	2	O	O
(	(	O	O
MRP2	mrp2	O	O
)	)	O	O
is	is	O	O
a	a	O	O
drug	drug	O	O
efflux	efflux	O	O
transporter	transporter	O	O
that	that	O	O
is	is	O	O
expressed	expressed	O	O
predominantly	predominantly	O	O
at	at	O	O
the	the	O	O
apical	apical	O	O
domain	domain	O	O
of	of	O	O
hepatocytes	hepatocytes	O	O
but	but	O	O
seems	seems	O	O
also	also	O	O
to	to	O	O
be	be	O	O
expressed	expressed	O	O
at	at	O	O
the	the	O	O
apical	apical	O	O
membrane	membrane	O	O
of	of	O	O
brain	brain	O	O
capillary	capillary	O	O
endothelial	endothelial	O	O
cells	cells	O	O
that	that	O	O
form	form	O	O
the	the	O	O
blood-brain	blood-brain	O	O
barrier	barrier	O	O
(	(	O	O
BBB	bbb	O	O
)	)	O	O
.	.	O	O

MRP2	mrp2	O	O
is	is	O	O
absent	absent	O	O
in	in	O	O
the	the	O	O
transport-deficient	transport-deficient	O	O
(	(	O	O
TR(-	tr(-	O	O
)	)	O	O
)	)	O	O
Wistar	wistar	O	O
rat	rat	O	O
mutant	mutant	O	O
,	,	O	O
so	so	O	O
that	that	O	O
this	this	O	O
rat	rat	O	O
strain	strain	O	O
was	was	O	O
very	very	O	O
helpful	helpful	O	O
in	in	O	O
defining	defining	O	O
substrates	substrates	O	O
of	of	O	O
MRP2	mrp2	O	O
by	by	O	O
comparing	comparing	O	O
tissue	tissue	O	O
concentrations	concentrations	O	O
or	or	O	O
functional	functional	O	O
activities	activities	O	O
of	of	O	O
compounds	compounds	O	O
in	in	O	O
MRP2-deficient	mrp2-deficient	O	O
rats	rats	O	O
with	with	O	O
those	those	O	O
in	in	O	O
transport-competent	transport-competent	O	O
Wistar	wistar	O	O
rats	rats	O	O
.	.	O	O

By	by	O	O
using	using	O	O
this	this	O	O
strategy	strategy	O	O
to	to	O	O
study	study	O	O
the	the	O	O
involvement	involvement	O	O
of	of	O	O
MRP2	mrp2	O	O
in	in	O	O
brain	brain	O	O
access	access	O	O
of	of	O	O
antiepileptic	antiepileptic	O	O
drugs	drugs	O	O
(	(	O	O
AEDs	aeds	O	O
)	)	O	O
,	,	O	O
we	we	O	O
recently	recently	O	O
reported	reported	O	O
that	that	O	O
phenytoin	phenytoin	S_chemical	O
is	is	O	O
a	a	O	O
substrate	substrate	O	O
for	for	O	O
MRP2	mrp2	O	O
in	in	O	O
the	the	O	O
BBB	bbb	O	O
.	.	O	O

However	however	O	O
,	,	O	O
one	one	O	O
drawback	drawback	O	O
of	of	O	O
such	such	O	O
studies	studies	O	O
in	in	O	O
genetically	genetically	O	O
deficient	deficient	O	O
rats	rats	O	O
is	is	O	O
the	the	O	O
fact	fact	O	O
that	that	O	O
compensatory	compensatory	O	O
changes	changes	O	O
with	with	O	O
upregulation	upregulation	O	O
of	of	O	O
other	other	O	O
transporters	transporters	O	O
can	can	O	O
occur	occur	O	O
.	.	O	O

This	this	O	O
prompted	prompted	O	O
us	us	O	O
to	to	O	O
study	study	O	O
the	the	O	O
brain	brain	O	O
expression	expression	O	O
of	of	O	O
P-glycoprotein	p-glycoprotein	O	O
(	(	O	O
Pgp	pgp	O	O
)	)	O	O
,	,	O	O
a	a	O	O
major	major	O	O
drug	drug	O	O
efflux	efflux	O	O
transporter	transporter	O	O
in	in	O	O
many	many	O	O
tissues	tissues	O	O
,	,	O	O
including	including	O	O
the	the	O	O
BBB	bbb	O	O
,	,	O	O
in	in	O	O
TR(-	tr(-	O	O
)	)	O	O
rats	rats	O	O
compared	compared	O	O
with	with	O	O
nonmutant	nonmutant	O	O
(	(	O	O
wild-type	wild-type	O	O
)	)	O	O
Wistar	wistar	O	O
rats	rats	O	O
.	.	O	O

METHODS	methods	O	O
:	:	O	O
The	the	O	O
expression	expression	O	O
of	of	O	O
MRP2	mrp2	O	O
and	and	O	O
Pgp	pgp	O	O
in	in	O	O
brain	brain	O	O
and	and	O	O
liver	liver	O	O
sections	sections	O	O
of	of	O	O
TR(-	tr(-	O	O
)	)	O	O
rats	rats	O	O
and	and	O	O
normal	normal	O	O
Wistar	wistar	O	O
rats	rats	O	O
was	was	O	O
determined	determined	O	O
with	with	O	O
immunohistochemistry	immunohistochemistry	O	O
,	,	O	O
by	by	O	O
using	using	O	O
a	a	O	O
novel	novel	O	O
,	,	O	O
highly	highly	O	O
selective	selective	O	O
monoclonal	monoclonal	O	O
MRP2	mrp2	O	O
antibody	antibody	O	O
and	and	O	O
the	the	O	O
monoclonal	monoclonal	O	O
Pgp	pgp	O	O
antibody	antibody	O	O
C219	c219	O	O
,	,	O	O
respectively	respectively	O	O
.	.	O	O

RESULTS	results	O	O
:	:	O	O
Immunofluorescence	immunofluorescence	O	O
staining	staining	O	O
with	with	O	O
the	the	O	O
MRP2	mrp2	O	O
antibody	antibody	O	O
was	was	O	O
found	found	O	O
to	to	O	O
label	label	O	O
a	a	O	O
high	high	O	O
number	number	O	O
of	of	O	O
microvessels	microvessels	O	O
throughout	throughout	O	O
the	the	O	O
brain	brain	O	O
in	in	O	O
normal	normal	O	O
Wistar	wistar	O	O
rats	rats	O	O
,	,	O	O
whereas	whereas	O	O
such	such	O	O
labeling	labeling	O	O
was	was	O	O
absent	absent	O	O
in	in	O	O
TR(-	tr(-	O	O
)	)	O	O
rats	rats	O	O
.	.	O	O

TR(-	tr(-	O	O
)	)	O	O
rats	rats	O	O
exhibited	exhibited	O	O
a	a	O	O
significant	significant	O	O
up-regulation	up-regulation	O	O
of	of	O	O
Pgp	pgp	O	O
in	in	O	O
brain	brain	O	O
capillary	capillary	O	O
endothelial	endothelial	O	O
cells	cells	O	O
compared	compared	O	O
with	with	O	O
wild-type	wild-type	O	O
controls	controls	O	O
.	.	O	O

No	no	O	O
such	such	O	O
obvious	obvious	O	O
upregulation	upregulation	O	O
of	of	O	O
Pgp	pgp	O	O
was	was	O	O
observed	observed	O	O
in	in	O	O
liver	liver	O	O
sections	sections	O	O
.	.	O	O

A	a	O	O
comparable	comparable	O	O
overexpression	overexpression	O	O
of	of	O	O
Pgp	pgp	O	O
in	in	O	O
the	the	O	O
BBB	bbb	O	O
was	was	O	O
obtained	obtained	O	O
after	after	O	O
pilocarpine-induced	pilocarpine-induced	O	O
seizures	seizures	O	S_disease
in	in	O	O
wild-type	wild-type	O	O
Wistar	wistar	O	O
rats	rats	O	O
.	.	O	O

Experiments	experiments	O	O
with	with	O	O
systemic	systemic	O	O
administration	administration	O	O
of	of	O	O
the	the	O	O
Pgp	pgp	O	O
substrate	substrate	O	O
phenobarbital	phenobarbital	S_chemical	O
and	and	O	O
the	the	O	O
selective	selective	O	O
Pgp	pgp	O	O
inhibitor	inhibitor	O	O
tariquidar	tariquidar	O	O
in	in	O	O
TR(-	tr(-	O	O
)	)	O	O
rats	rats	O	O
substantiated	substantiated	O	O
that	that	O	O
Pgp	pgp	O	O
is	is	O	O
functional	functional	O	O
and	and	O	O
compensates	compensates	O	O
for	for	O	O
the	the	O	O
lack	lack	O	O
of	of	O	O
MRP2	mrp2	O	O
in	in	O	O
the	the	O	O
BBB	bbb	O	O
.	.	O	O

CONCLUSIONS	conclusions	O	O
:	:	O	O
The	the	O	O
data	data	O	O
on	on	O	O
TR(-	tr(-	O	O
)	)	O	O
rats	rats	O	O
indicate	indicate	O	O
that	that	O	O
Pgp	pgp	O	O
plays	plays	O	O
an	an	O	O
important	important	O	O
role	role	O	O
in	in	O	O
the	the	O	O
compensation	compensation	O	O
of	of	O	O
MRP2	mrp2	O	O
deficiency	deficiency	O	O
in	in	O	O
the	the	O	O
BBB	bbb	O	O
.	.	O	O

Because	because	O	O
such	such	O	O
a	a	O	O
compensatory	compensatory	O	O
mechanism	mechanism	O	O
most	most	O	O
likely	likely	O	O
occurs	occurs	O	O
to	to	O	O
reduce	reduce	O	O
injury	injury	O	O
to	to	O	O
the	the	O	O
brain	brain	O	O
from	from	O	O
cytotoxic	cytotoxic	O	O
compounds	compounds	O	O
,	,	O	O
the	the	O	O
present	present	O	O
data	data	O	O
substantiate	substantiate	O	O
the	the	O	O
concept	concept	O	O
that	that	O	O
MRP2	mrp2	O	O
performs	performs	O	O
a	a	O	O
protective	protective	O	O
role	role	O	O
in	in	O	O
the	the	O	O
BBB	bbb	O	O
.	.	O	O

Furthermore	furthermore	O	O
,	,	O	O
our	our	O	O
data	data	O	O
suggest	suggest	O	O
that	that	O	O
TR(-	tr(-	O	O
)	)	O	O
rats	rats	O	O
are	are	O	O
an	an	O	O
interesting	interesting	O	O
tool	tool	O	O
to	to	O	O
study	study	O	O
consequences	consequences	O	O
of	of	O	O
overexpression	overexpression	O	O
of	of	O	O
Pgp	pgp	O	O
in	in	O	O
the	the	O	O
BBB	bbb	O	O
on	on	O	O
access	access	O	O
of	of	O	O
drugs	drugs	O	O
in	in	O	O
the	the	O	O
brain	brain	O	O
,	,	O	O
without	without	O	O
the	the	O	O
need	need	O	O
of	of	O	O
inducing	inducing	O	O
seizures	seizures	O	S_disease
or	or	O	O
other	other	O	O
Pgp-enhancing	pgp-enhancing	O	O
events	events	O	O
for	for	O	O
this	this	O	O
purpose	purpose	O	O
.	.	O	O

